Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
2.640
-0.100 (-3.65%)
At close: Oct 29, 2024, 4:00 PM
2.720
+0.080 (3.03%)
After-hours: Oct 29, 2024, 7:42 PM EDT
Inhibikase Therapeutics Market Cap
Inhibikase Therapeutics has a market cap or net worth of $177.39 million as of October 29, 2024. Its market cap has increased by 3,447.77% in one year.
Market Cap
177.39M
Enterprise Value
169.80M
1-Year Change
3,447.77%
Ranking
Category
Stock Price
$2.64
Market Cap Chart
Since the IPO on December 23, 2020, Inhibikase Therapeutics's market cap has increased from $100.46M to $177.39M, an increase of 76.58%. That is a compound annual growth rate of 15.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 20.50M | 162.82% |
| Dec 29, 2023 | 7.80M | -38.10% |
| Dec 30, 2022 | 12.60M | -65.95% |
| Dec 31, 2021 | 37.00M | -44.19% |
| Dec 31, 2020 | 66.30M | -34.00% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tonix Pharmaceuticals Holding | 25.06M |
| Inspira Technologies Oxy B.H.N. | 24.79M |
| The Oncology Institute | 24.55M |
| Precision Optics Corporation | 24.51M |
| Ekso Bionics Holdings | 24.39M |
| Spruce Biosciences | 24.30M |
| NeuroBo Pharmaceuticals | 24.19M |
| Lisata Therapeutics | 23.96M |